Top 10 most significant DEGs. by Foluwasomi A. Oyefeso (15999113)

The profile of the 263 significant differentially expressed metabolites (DEMs). by Haiying Yang (11707725)

Subjects:

Differentially expressed genes (DEGs) between PMR and HC. by Xinlei Ma (1423633)

Subjects:

Differentially expressed genes (DEGs) between PMR and PMR-R. by Xinlei Ma (1423633)

Subjects:

Differentially expressed genes (DEGs) between PMR-R and HC. by Xinlei Ma (1423633)

Subjects:

Database of the significantly enriched gene ontology terms of the DEGs. by Camilo Escobar-Sierra (18150360)

Increase in physical activity (100 step, 500 steps or 1000 steps) after the challenge according to decrease in screen time < or ≥60 minutes. by Annaëlle Le Steunf (19838110)

The test steps. by Ruihong Wang (1932328)

Gene set enrichment analysis with identified DEG (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s compared to unstimulated ILC2s (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance). by Christina Gress (11536883)

“…<p>Gene set enrichment analysis with identified DEG (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s compared to unstimulated ILC2s (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).…”

Visualisation of significantly differentially expressed genes (DEGs). by Mohammed A. Alfattah (18271622)

Significantly Enriched Pathways. by Jiyong Zhang (2498740)

Subjects:

Late onset DEG (identified at later timepoints) from significant pathways. by Sung-Hyun Park (196247)

DEG KEGG pathway. by Xinzhuan Yao (10095316)

The influence of the controlled pH conditions at the sample preparation step on the obtained signals (panel A: extraction using a mixture of MeOH and EtOH; panel B: extraction usin... by Ewa Paszkowska (21246702)

Subjects:

Summary of top five significant pathways enriched by the 345 late onset DEG. by Sung-Hyun Park (196247)

Differentially expressed genes (DEGs) exhibiting both increased and decreased expression levels. by Liwen Wang (276995)

Gene set enrichment analysis with identified DEGs (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s pre-incubated with the selective DP₂ antagonist fevipiprant compared to metabolite activated ILC2s without fevipiprant stimulation (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance). by Christina Gress (11536883)

“…<p>Gene set enrichment analysis with identified DEGs (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s pre-incubated with the selective DP₂ antagonist fevipiprant compared to metabolite activated ILC2s without fevipiprant stimulation (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).…”

Significantly activated/inactivated canonical pathways in the DEGs induced by iso-α-acids intake. by Takahito Takase (10104912)

Proteins from volcano plot which had notable increases or decreases listed in order of greatest to least significance (adjusted p-values). by Eiman Y. Ibrahim (10731078)

Increasing TPP side chain length decreases melanoma cell viability and clonogenic survival. by Kyle C. Kloepping (9928265)

“…Results demonstrate that TPP derivatives decrease melanoma cell viability and clonogenic survival; and there is a structure-activity relationship between TPP side chain length and decreased viability and clonogenic survival.…”